Haemonetics SG&A Expense (Annual) Insights

Haemonetics Corp (HAE)

77.89 -0.19 (-0.24%) USD | NYSE | Oct 04, 16:00

77.85 -0.04 (-0.05%) After-Hours: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 1992. Upgrade now.

Date	Value
March 31, 2024	431.78M
March 31, 2023	376.68M
March 31, 2022	340.14M
March 31, 2021	275.22M
March 31, 2020	282.02M
March 31, 2019	273.47M
March 31, 2018	316.52M
March 31, 2017	301.73M
March 31, 2016	317.22M
March 31, 2015	337.17M
March 31, 2014	365.98M
March 31, 2013	323.05M
March 31, 2012	245.26M
March 31, 2011	213.90M
March 31, 2010	214.48M
March 31, 2009	198.74M
March 31, 2008	163.12M

Date	Value
March 31, 2007	137.07M
March 31, 2006	121.35M
March 31, 2005	118.04M
March 31, 2004	108.84M
March 31, 2003	97.70M
March 31, 2002	88.87M
March 31, 2001	86.73M
March 31, 2000	82.90M
March 31, 1999	86.88M
March 31, 1998	86.90M
March 31, 1997	88.10M
March 31, 1996	81.80M
March 31, 1995	75.70M
March 31, 1994	75.90M
March 31, 1993	77.20M
March 31, 1992	61.00M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

275.22M

Minimum

2021

431.78M

Maximum

2024

341.17M

Average

340.14M

Median

2022

SG&A Expense (Annual) Benchmarks